» Articles » PMID: 39857654

Normothermic Crystalloid Polarizing Cardioplegia Improves Systolic and Diastolic Function in a Porcine Model of Cardiopulmonary Bypass

Overview
Journal Biomedicines
Date 2025 Jan 25
PMID 39857654
Authors
Affiliations
Soon will be listed here.
Abstract

Previously, we showed that blood-based polarizing cardioplegia exerted beneficial cardioprotection during hypothermic ischemia; however, these positive effects of blood-based polarizing cardioplegia were reduced during normothermic ischemia compared to blood-based hyperkalemic (depolarizing) cardioplegia. This study compares crystalloid polarizing cardioplegia to crystalloid depolarizing cardioplegia in a normothermic porcine model of cardiopulmonary bypass; Methods: Twelve pigs were randomized to receive either normothermic polarizing ( = 7) or depolarizing ( = 5) crystalloid cardioplegia. After the initiation of cardiopulmonary bypass, normothermic arrest (34 °C, 60 min) was followed by 60 min of on-pump and 90 min of off-pump reperfusion. Myocardial injury (arterial CK-MB), hemodynamic function, and the energy status of the hearts were measured; Results: The arterial release of CK-MB was comparable between groups ( = 0.78) during reperfusion. During 150 min of reperfusion, systolic left ventricular pressure ( = 0.01) and coronary flow ( = 0.009) were increased, and wedge pressure ( = 0.04) was decreased in the polarized group. Further hemodynamic parameters (cardiac output, stroke volume) and high-energy phosphate levels were similar between groups. The requirement for noradrenaline administration during reperfusion was significantly higher ( = 0.013) in the polarized group; Conclusions: Under normothermic conditions and despite a similar increase in levels of cardiac CK-MB, crystalloid polarizing cardioplegia protected systolic and diastolic cardiac function after 60 min of cardiac arrest. These results suggest beneficial effects for polarizing cardioplegia; clinical studies are required to confirm these effects.

References
1.
Santer D, Kramer A, Kiss A, Aumayr K, Hackl M, Heber S . St Thomas' Hospital polarizing blood cardioplegia improves hemodynamic recovery in a porcine model of cardiopulmonary bypass. J Thorac Cardiovasc Surg. 2019; 158(6):1543-1554.e8. DOI: 10.1016/j.jtcvs.2018.11.104. View

2.
Skalidis E, Hamilos M, Chlouverakis G, Kochiadakis G, Parthenakis F, Vardas P . Acute effect of esmolol intravenously on coronary microcirculation in patients with idiopathic dilated cardiomyopathy. Am J Cardiol. 2007; 100(8):1299-302. DOI: 10.1016/j.amjcard.2007.05.055. View

3.
Rinne T, Harmoinen A, Kaukinen S . Esmolol cardioplegia in unstable coronary revascularisation patients. A randomised clinical trial. Acta Anaesthesiol Scand. 2000; 44(6):727-32. DOI: 10.1034/j.1399-6576.2000.440611.x. View

4.
Ruetzler K, Smilowitz N, Berger J, Devereaux P, Maron B, Newby L . Diagnosis and Management of Patients With Myocardial Injury After Noncardiac Surgery: A Scientific Statement From the American Heart Association. Circulation. 2021; 144(19):e287-e305. DOI: 10.1161/CIR.0000000000001024. View

5.
Shimosawa T, Takano K, Ando K, Fujita T . Magnesium inhibits norepinephrine release by blocking N-type calcium channels at peripheral sympathetic nerve endings. Hypertension. 2004; 44(6):897-902. DOI: 10.1161/01.HYP.0000146536.68208.84. View